Non-islet-cell tumour induced hypoglycaemia: A case report and review of literature

Netherlands Journal of Medicine

Volumn 48, Issue 5, 1996, Pages 175-179

  Kuenen, B C ^a   Van Doorn, J ^b   Slee, P H Th J ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adenocarcinoma, rectum; Hypoglycaemia: 'Big' IGF II

Indexed keywords

GLUCOSE; SOMATOMEDIN B;

ADULT; ARTICLE; CASE REPORT; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; LIVER METASTASIS; MALE; NEGATIVE FEEDBACK; RECTUM CARCINOMA;

EID: 0029924789     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-2977(95)00073-9     Document Type: Article

References (16)

1. Eastman RC, Barbetti F, Roberts Jr CT, LeRoith D. Hypoglycemia due to production of hypoglycemic factors by nonislet-cell tumors. In: Mazzaferri EL, Samaan NA, eds. Endocrine tumors. Oxford: Blackwell Scientific Publications, 1993;687-699.
2. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988;319:1434-1440.
3. Daughaday WH, Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 1989;86:6778-6782.
4. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 1990;85:1672-1679.
5. Zapf J, Futo E, Peter M, Froesch ER. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapacreatic tumor hypoglycemia? J Clin Invest 1992;90:2574-2584.
6. Nielsen FC, Orskov C, Haselbacher G et al. Insulin-like growth factor II mRNA, peptides, and receptors in a thoracopulmonary malignant small round cell tumor. Cancer 1994;73:1312-1319.
7. Hoekman K, van Doorn J, Gloudemans T, et al. Tumour-induced hypoglycaemia: a case report. Ann Oncol 1994;5:277-281.
8. Philips LS, Robertson DG. Insulin-like growth factors and non-islet cell tumor hypoglycemia. Metabolism 1993; 42:1093-1101.
9. Jansen J, Van Buul-Offers SC, Hoogerbrugge CM, Van den Brande JL. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies. Biochem J 1990;266:513-520.
10. Silbergeld A, Litwin A, Bruchis S, Varsano I, Laron Z. Insulin-like growth factor I (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clin Endocrinol 1986;25:67-74.
11. Van den Brande JL, Jansen M, Hoogerbrugge CM, et al. Molecular aspects of the human somatomedins. Horm Res 1986;24:131-140.
12. Hardouin S, Hossenlopp P, Segovia B, et al. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man. Eur J Biochem 1987;170:121-132.
13. Zapf J. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res 1994;42:20-26.
14. Baxter RC, Daughaday WH. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab 1991;73:696-702.
15. Daughady WH, Trivedi B, Baxter RC. Serum "big insulin-like growth factor II" from patients with tumor-induced hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 1993;90;5823-5827.
16. Blum WF, Horn N, Kratsch J, et al. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 1993;3:100-104.